Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 USD | -4.81% | -15.62% | -10.76% |
Mar. 06 | Transcript : ESSA Pharma Inc. - Shareholder/Analyst Call | |
Mar. 06 | Norway's wealth fund pushes for more women on emerging market company boards | RE |
Business Summary
Number of employees: 50
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Chief Tech/Sci/R&D Officer | 63 | 19-07-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Director/Board Member | 55 | 19-07-30 | |
Scott Requadt
BRD | Director/Board Member | 56 | 16-01-13 |
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
Philip Kantoff
BRD | Director/Board Member | 69 | 22-09-12 |
Ann Thorell
BRD | Director/Board Member | 56 | 19-07-30 |
Gary Sollis
BRD | Director/Board Member | 69 | 12-04-25 |
Lauren Merendino
BRD | Director/Board Member | 49 | 23-06-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,238,147 | 43,230,993 ( 97.72 %) | 0 | 97.72 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.76% | 276M | |
+26.52% | 44.96B | |
-0.79% | 42.65B | |
+46.00% | 41.85B | |
-5.31% | 29.04B | |
+9.46% | 26.08B | |
-21.48% | 19.03B | |
+6.09% | 12.75B | |
+27.77% | 12.06B | |
-3.40% | 11.75B |
- Stock Market
- Equities
- EPIX Stock
- Company ESSA Pharma Inc.